Skip to main content
. 2020 Sep 4;43(11):2702–2712. doi: 10.2337/dc20-0557

Table 2.

Cross-sectional associations, geometric mean (95% CI), between rest-activity rhythm characteristics and metabolic markers

Fasting glucose, mmol/L Fasting insulin, pmol/L HOMA-IR
Model 1a Model 2b Model 1a Model 2b Model 1a Model 2b
Overall No medicationc Overall No medicationc Overall No medicationc
Amplitude
 Q1 5.56 (5.47, 5.66)** 5.55 (5.46, 5.65)** 5.59 (5.50, 5.67) 92.67 (88.01, 97.58)*** 91.56 (86.98, 96.38)*** 89.52 (84.88, 94.42)*** 3.82 (3.61, 4.05)*** 3.77 (3.56, 4.00)*** 3.60 (3.39, 3.82)***
 Q2 5.44 (5.35, 5.53) 5.45 (5.36, 5.54) 5.5 (5.42, 5.59) 87.35 (83.07, 91.84)*** 87.46 (83.22, 91.91)*** 85.88 (81.58, 90.41)*** 3.53 (3.33, 3.73)*** 3.54 (3.34, 3.74)*** 3.40 (3.21, 3.60)**
 Q3 5.42 (5.33, 5.51) 5.43 (5.34, 5.52) 5.51 (5.42, 5.59) 81.17 (77.20, 85.34) 80.50 (76.60, 84.59) 79.67 (75.71, 83.84) 3.26 (3.08, 3.46) 3.24 (3.07, 3.43) 3.16 (2.98, 3.34)
 Q4 (ref) 5.42 (5.36, 5.48) 5.42 (5.36, 5.48) 5.34 (5.28, 5.39) 79.08 (76.28, 81.98) 79.08 (76.28, 81.98) 78.58 (75.70, 81.58) 3.18 (3.05, 3.31) 3.18 (3.05, 3.31) 3.11 (2.98, 3.24)
Ptrend 0.005 0.007 0.09 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Mesor
 Q1 5.50 (5.40, 5.59) 5.52 (5.43, 5.62) 5.39 (5.30, 5.47) 88.83 (84.40, 93.50)*** 88.50 (84.12, 93.12)*** 86.61 (82.16, 91.31)** 3.62 (3.41, 3.83)*** 3.62 (3.42, 3.84)*** 3.46 (3.26, 3.67)**
 Q2 5.41 (5.32, 5.50) 5.43 (5.35, 5.53) 5.34 (5.26, 5.42) 85.80 (81.59, 90.22)* 86.02 (81.85, 90.39)** 85.20 (80.95, 89.69)** 3.44 (3.25, 3.64)* 3.46 (3.27, 3.66)* 3.37 (3.19, 3.57)*
 Q3 5.44 (5.35, 5.54) 5.45 (5.36, 5.54) 5.37 (5.29, 5.45) 82.16 (78.13, 86.40) 81.48 (77.54, 85.63) 80.52 (76.51, 84.75) 3.31 (3.13, 3.51) 3.29 (3.11, 3.48) 3.21 (3.03, 3.40)
 Q4 (ref) 5.44 (5.38, 5.51) 5.44 (5.38, 5.51) 5.34 (5.29, 5.40) 80.41 (77.58, 83.34) 80.41 (77.58, 83.34) 79.56 (76.65, 82.57) 3.24 (3.12, 3.38) 3.24 (3.12, 3.38) 3.15 (3.03, 3.28)
Ptrend 0.38 0.12 0.42 <0.0001 <0.0001 0.0003 <0.0001 <0.0001 0.0003
Amplitude-to-  mesor ratio
 Q1 5.54 (5.45, 5.64)* 5.51 (5.41, 5.60) 5.41 (5.32, 5.49) 91.16 (86.57, 95.98)*** 90.83 (86.30, 95.59)*** 88.37 (83.80, 93.19)*** 3.75 (3.54, 3.98)*** 3.71 (3.51, 3.94)*** 3.54 (3.34, 3.75)***
 Q2 5.45 (5.36, 5.55) 5.45 (5.36, 5.54) 5.36 (5.27, 5.44) 85.48 (81.27, 89.90)* 85.84 (81.67, 90.21)** 84.73 (80.48, 89.21)* 3.46 (3.27, 3.67)* 3.47 (3.28, 3.68)* 3.36 (3.18, 3.56)*
 Q3 5.36 (5.27, 5.45) 5.38 (5.29, 5.47) 5.29 (5.21, 5.37) 81.59 (77.60, 85.79) 82.80 (78.80, 87.00) 81.72 (77.65, 86.00) 3.25 (3.07, 3.44) 3.31 (3.13, 3.50) 3.20 (3.03, 3.39)
 Q4 (ref) 5.44 (5.38, 5.51) 5.44 (5.38, 5.51) 5.35 (5.29, 5.40) 80.18 (77.38, 83.07) 80.18 (77.38, 83.07) 79.47 (76.58, 82.46) 3.24 (3.11, 3.37) 3.24 (3.11, 3.37) 3.15 (3.03, 3.28)
Ptrend 0.009 0.09 0.11 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Pseudo-F
 Q1 5.55 (5.45, 5.64)* 5.52 (5.43, 5.62) 5.41 (5.32, 5.49) 91.33 (86.75, 96.15)*** 90.26 (85.74, 95.02)*** 88.23 (83.64, 93.07)*** 3.76 (3.55, 3.99)*** 3.71 (3.50, 3.93)*** 3.54 (3.33, 3.76)***
 Q2 5.43 (5.34, 5.52) 5.43 (5.34, 5.52) 5.34 (5.26, 5.43) 86.34 (82.10, 90.81)** 85.78 (81.59, 90.20)** 84.36 (80.10, 88.83)* 3.48 (3.29, 3.69)** 3.46 (3.27, 3.66** 3.34 (3.16, 3.54)*
 Q3 5.38 (5.29, 5.47) 5.38 (5.29, 5.47) 5.31 (5.23, 5.39) 81.22 (77.26, 85.38) 81.57 (77.63, 85.71) 80.38 (76.37, 84.59) 3.25 (3.07, 3.44) 3.26 (3.08, 3.45) 3.17 (2.99, 3.35)
 Q4 (ref) 5.44 (5.38, 5.51) 5.44 (5.38, 5.51) 5.34 (5.28, 5.40) 79.41 (76.62, 82.30) 79.41 (76.62, 82.30) 79.01 (76.11, 82.01) 3.21 (3.08, 3.34) 3.21 (3.08, 3.34) 3.13 (3.00, 3.26)
Ptrend 0.02 0.05 0.1 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Acrophased
 Early 5.53 (5.43, 5.63) 5.47 (5.37, 5.56) 5.32 (5.24, 5.41) 92.32 (87.66, 97.24) 90.43 (85.87, 95.22) 87.87 (83.31, 92.68) 3.78 (3.57, 4.01) 3.67 (3.46, 3.89) 3.48 (3.28, 3.69)
 Normal (ref) 5.50 (5.40, 5.60) 5.50 (5.40, 5.60) 5.37 (5.28, 5.46) 87.78 (83.64, 92.12) 87.78 (83.64, 92.12) 86.45 (82.17, 90.95) 3.58 (3.39, 3.78) 3.58 (3.39, 3.78) 3.44 (3.25, 3.64)
 Late 5.58 (5.28, 5.91) 5.58 (5.28, 5.91) 5.37 (5.28, 5.46) 94.13 (89.15, 99.39)* 92.23 (87.36, 97.38) 90.89 (85.85, 96.21) 3.89 (3.65, 4.13) 3.79 (3.57, 4.04) 3.63 (3.41, 3.87)
Ptrend 0.57 0.21 0.41 0.68 0.64 0.41 0.68 0.64 0.41

ref, reference.

a

Models were adjusted for age alone.

b

Models were adjusted for age, study site, education, marital status, race, smoking, alcohol, healthy diet score, and season of data collection.

c

Excluded 178 people who reported using hypoglycemic medications or insulin at baseline.

d

Acrophase was categorized as early (mean − 1 SD, before 1304 h), normal (mean ± 1 SD, between 1304 and 1529 h), and late (mean + 1 SD, after 1529 h).

*

P value <0.05,

**

P value <0.01,

***

P value <0.001.